Energetics of Endotoxin Recognition in the Toll-Like Receptor 4 Innate Immune Response

被引:22
|
作者
Paramo, Teresa [1 ]
Tomasio, Susana M. [1 ]
Irvine, Kate L. [2 ]
Bryant, Clare E. [2 ]
Bond, Peter J. [3 ,4 ]
机构
[1] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England
[2] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England
[3] Bioinformat Inst A STAR, Singapore 138671, Singapore
[4] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
基金
英国生物技术与生命科学研究理事会;
关键词
OUTER-MEMBRANE PERMEABILITY; MOLECULAR-DYNAMICS; LIPID-A; TERTIARY STRUCTURE; MONOMERIC ENDOTOXIN; STRUCTURAL BASIS; CELL-ENVELOPE; MITE ALLERGEN; ROUGH MUTANT; HUMAN MD-2;
D O I
10.1038/srep17997
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bacterial outer membrane lipopolysaccharide (LPS) potently stimulates the mammalian innate immune system, and can lead to sepsis, the primary cause of death from infections. LPS is sensed by Toll-like receptor 4 (TLR4) in complex with its lipid-binding coreceptor MD-2, but subtle structural variations in LPS can profoundly modulate the response. To better understand the mechanism of LPS-induced stimulation and bacterial evasion, we have calculated the binding affinity to MD-2 of agonistic and antagonistic LPS variants including lipid A, lipid IVa, and synthetic antagonist Eritoran, and provide evidence that the coreceptor is a molecular switch that undergoes ligand-induced conformational changes to appropriately activate or inhibit the receptor complex. The plasticity of the coreceptor binding cavity is shown to be essential for distinguishing between ligands, whilst similar calculations for a model bacterial LPS bilayer reveal the "membrane-like" nature of the protein cavity. The ability to predict the activity of LPS variants should facilitate the rational design of TLR4 therapeutics.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The role of Toll-like receptor 4 polymorphisms in vaccine immune response
    P Pellegrino
    F S Falvella
    S Cheli
    C Perrotta
    E Clementi
    S Radice
    The Pharmacogenomics Journal, 2016, 16 : 96 - 101
  • [22] The role of Toll-like receptor 4 polymorphisms in vaccine immune response
    Pellegrino, P.
    Falvella, F. S.
    Cheli, S.
    Perrotta, C.
    Clementi, E.
    Radice, S.
    PHARMACOGENOMICS JOURNAL, 2016, 16 (01): : 96 - 101
  • [23] Variability among Macaca fascicularis in the innate immune response to Toll-like receptor 4 (TLR4) agonists
    Frevert, Charles Wayne
    Hukkanen, Renee
    Mongovin, Steve
    Larsen, Kay
    Agy, Mike
    Martin, Thomas
    Wurfel, Mark
    FASEB JOURNAL, 2008, 22
  • [24] MIF regulates innate immune responses through modulation of Toll-like receptor 4
    Roger, T
    David, J
    Glauser, MP
    Calandra, T
    NATURE, 2001, 414 (6866) : 920 - 924
  • [25] MIF regulates innate immune responses through modulation of Toll-like receptor 4
    Thierry Roger
    John David
    Michel P. Glauser
    Thierry Calandra
    Nature, 2001, 414 : 920 - 924
  • [26] Toll-Like Receptor-4 Coordinates the Innate Immune Response of the Kidney to Renal Ischemia/Reperfusion Injury
    Pulskens, Wilco P.
    Teske, Gwendoline J.
    Butter, Loes M.
    Roelofs, Joris J.
    van der Poll, Tom
    Florquin, Sandrine
    Leemans, Jaklien C.
    PLOS ONE, 2008, 3 (10):
  • [27] Innate immune recognition of nucleic acids: Beyond toll-like receptors
    Ishii, KJ
    Akira, S
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (04) : 517 - 523
  • [28] Evolution and integration of innate immune recognition systems: the Toll-like receptors
    Takeda, K
    JOURNAL OF ENDOTOXIN RESEARCH, 2005, 11 (01): : 51 - 55
  • [29] Toll-like receptor and innate immunity
    Uematsu, Satoshi
    Akira, Shizuo
    SEIKAGAKU, 2007, 79 (08): : 769 - 776
  • [30] Phylogeny of Toll-Like Receptor Signaling: Adapting the Innate Response
    Roach, Jeffrey M.
    Racioppi, Luigi
    Jones, Corbin D.
    Masci, Anna Maria
    PLOS ONE, 2013, 8 (01):